We are live on ! Find out more
DAWN

Day One Biopharmaceuticals
DAWN

Delisted

DAWN was delisted on the 22nd of April, 2026.

Back to rankings

140 hedge funds and large institutions have $941M invested in Day One Biopharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 60 increasing their positions, 23 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

161% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 23

56% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 25

33% more call options, than puts

Call options by funds: $1.74M | Put options by funds: $1.31M

23.94% more ownership

Funds ownership: 83.18% → 107.12% (+24%)

15% more capital invested

Capital invested by funds: $818M → $941M (+$123M)

11% more funds holding

Funds holding: 126 → 140 (+14)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
140
Holders Change
+14
Holders Change %
+11.11%
% of All Funds
2.2%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
39
Increased
60
Reduced
23
Closed
25
Calls
$1.74M
Puts
$1.31M
Net Calls
+$429K
Net Calls Change
-$526K

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$22.2M
2
BlackRock
BlackRock
New York
+$17.1M
3
DM
Deerfield Management
New York
+$16.6M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$15M
5
PHS
PFM Health Sciences
California
+$15M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$13.2M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$5.38M
3
Renaissance Technologies
Renaissance Technologies
New York
-$3.13M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$2.76M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$2.36M
Name Holding Trade Value Shares
Change 		Change in
Stake
Legal & General Group
76
Legal & General Group
United Kingdom
$586K +$608K +46,515 +1,799%
AG
77
Algert Global
California
$585K +$413K +31,622 +182%
State of Wisconsin Investment Board
78
State of Wisconsin Investment Board
Wisconsin
$552K +$603K +46,196 New
LCM
79
Legato Capital Management
California
$522K +$179K +13,696 +46%
AllianceBernstein
80
AllianceBernstein
Tennessee
$517K +$77.2K +5,910 +16%
Bank of Montreal
81
Bank of Montreal
Ontario, Canada
$507K +$495K +37,895 New
DKCM
82
Davidson Kempner Capital Management
New York
$477K +$522K +40,000 New
VOYA Investment Management
83
VOYA Investment Management
Georgia
$439K +$116K +8,889 +32%
Jane Street
84
Jane Street
New York
$437K -$810K -61,984 -63%
Fisher Asset Management
85
Fisher Asset Management
Washington
$432K – – –
Mirae Asset Global Investments
86
Mirae Asset Global Investments
South Korea
$422K +$165K +12,647 +56%
MAM
87
Martingale Asset Management
Massachusetts
$359K -$24.8K -1,900 -6%
HWAM
88
Hennion & Walsh Asset Management
New Jersey
$339K +$371K +28,389 New
Tudor Investment Corp
89
Tudor Investment Corp
Connecticut
$336K +$222K +17,035 +153%
TD Asset Management
90
TD Asset Management
Ontario, Canada
$330K – – –
MIM
91
MetLife Investment Management
New Jersey
$315K +$141K +10,833 +70%
Vontobel Holding
92
Vontobel Holding
Switzerland
$284K +$311K +23,800 New
AIG
93
American International Group
New York
$283K +$135K +10,333 +77%
DTL
94
Dynamic Technology Lab
Singapore
$279K -$232K -17,796 -43%
SG Americas Securities
95
SG Americas Securities
New York
$278K +$80.2K +6,140 +36%
XT
96
XTX Topco
Cayman Islands
$204K -$46.1K -3,533 -17%
GT
97
Glenmede Trust
Pennsylvania
$203K – – –
Two Sigma Advisers
98
Two Sigma Advisers
New York
$196K +$214K +16,400 New
Principal Financial Group
99
Principal Financial Group
Iowa
$194K +$32.6K +2,499 +18%
Invesco
100
Invesco
Georgia
$192K +$210K +16,094 New
2 3
4
5 6

DAWN Hedge Fund Activity: Q2 2023 in Review

140 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Day One Biopharmaceuticals (DAWN) for Q2 2023, worth a combined $941M — up 15% from $818M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new DAWN positions and 25 closed out — a net gain of 14 holders — while 60 added to existing stakes and 23 trimmed.

The largest buyer was Adage Capital Partners, adding an estimated $22.2M. The largest seller was Fidelity Investments, cutting an estimated $13.2M.

  • 140 institutional investors held Day One Biopharmaceuticals (DAWN) as of Q2 2023, up from 126 in Q1 2023.
  • Funds reported $941M of Day One Biopharmaceuticals stock for Q2 2023, up 15% quarter-over-quarter.
  • 39 funds opened new Day One Biopharmaceuticals positions in Q2 2023 and 25 closed out, a net change of +14 holders.
  • The largest Day One Biopharmaceuticals buyer in Q2 2023 was Adage Capital Partners, an estimated $22.2M added.
  • The largest Day One Biopharmaceuticals seller in Q2 2023 was Fidelity Investments, an estimated $13.2M sold.

Based on aggregated 13F filings for Q2 2023.